JP2008513472A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513472A5
JP2008513472A5 JP2007532479A JP2007532479A JP2008513472A5 JP 2008513472 A5 JP2008513472 A5 JP 2008513472A5 JP 2007532479 A JP2007532479 A JP 2007532479A JP 2007532479 A JP2007532479 A JP 2007532479A JP 2008513472 A5 JP2008513472 A5 JP 2008513472A5
Authority
JP
Japan
Prior art keywords
hydrogen
haloalkyl
alkyl
haloalkoxy
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007532479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/033051 external-priority patent/WO2006034004A2/en
Publication of JP2008513472A publication Critical patent/JP2008513472A/ja
Publication of JP2008513472A5 publication Critical patent/JP2008513472A5/ja
Pending legal-status Critical Current

Links

JP2007532479A 2004-09-17 2005-09-16 システインプロテアーゼインヒビターの調製のための方法及び中間体 Pending JP2008513472A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61080604P 2004-09-17 2004-09-17
PCT/US2005/033051 WO2006034004A2 (en) 2004-09-17 2005-09-16 Processes and intermediates for preparing cysteine protease inhibitors

Publications (2)

Publication Number Publication Date
JP2008513472A JP2008513472A (ja) 2008-05-01
JP2008513472A5 true JP2008513472A5 (enExample) 2008-07-03

Family

ID=35899659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532479A Pending JP2008513472A (ja) 2004-09-17 2005-09-16 システインプロテアーゼインヒビターの調製のための方法及び中間体

Country Status (15)

Country Link
US (1) US7737300B2 (enExample)
EP (1) EP1799645A2 (enExample)
JP (1) JP2008513472A (enExample)
KR (1) KR20070061877A (enExample)
CN (1) CN101068783A (enExample)
AU (1) AU2005287046A1 (enExample)
BR (1) BRPI0515470A (enExample)
CA (1) CA2580065A1 (enExample)
CR (1) CR8993A (enExample)
EC (1) ECSP077321A (enExample)
IL (1) IL181792A0 (enExample)
MX (1) MX2007003118A (enExample)
NO (1) NO20071937L (enExample)
WO (1) WO2006034004A2 (enExample)
ZA (1) ZA200703102B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005028429A2 (en) 2003-09-18 2005-03-31 Axys Pharmaceuticals, Inc. Haloalkyl containing compounds as cysteine protease inhibitors
EP1819667B1 (en) 2004-12-02 2012-10-17 ViroBay, Inc. Sulfonamide compounds as cysteine protease inhibitors
HRP20130419T1 (en) 2005-03-21 2013-06-30 Virobay, Inc. Alpha ketoamide compounds as cysteine protease inhibitors
MX2007011739A (es) 2005-03-22 2008-03-14 Celera Genomics Compuestos que contienen sulfonilo como inhibidores de cisteina proteasa.
EP2064178A4 (en) * 2006-09-08 2011-10-05 Merck Canada Inc PRODRUGS OF INHIBITORS OF CATHEPSIN S
WO2008037072A1 (en) 2006-09-25 2008-04-03 Merck Frosst Canada Ltd. Cathepsin b inhibitors
DK2079683T3 (en) 2006-10-04 2015-04-27 Virobay Inc Difluoro-containing compounds as cysteine protease inhibitors
US7893112B2 (en) 2006-10-04 2011-02-22 Virobay, Inc. Di-fluoro containing compounds as cysteine protease inhibitors
WO2008070994A1 (en) 2006-12-14 2008-06-19 Nps Pharmaceuticals, Inc. Use of d-serine derivatives for the treatment of anxiety disorders
CN101668736B (zh) 2007-04-02 2013-06-12 默克弗罗斯特加拿大有限公司 用于制备组织蛋白酶k抑制剂的酰胺化反应
PT2350090E (pt) 2008-10-17 2015-11-13 Xenon Pharmaceuticals Inc Composto espiro-oxindol e suas utilizações como agentes terapêuticos
WO2010148488A1 (en) * 2009-06-22 2010-12-29 Merck Frosst Canada Ltd. Cathepsin cysteine protease inhibitors for the treatment of various diseases
US8324417B2 (en) 2009-08-19 2012-12-04 Virobay, Inc. Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof
WO2012119941A1 (en) 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
CN104039151A (zh) * 2011-06-17 2014-09-10 维罗贝股份有限公司 治疗中枢神经系统中小神经胶质细胞介导的神经元缺失的组织蛋白酶抑制剂
EP3342765B1 (en) * 2015-08-29 2021-09-15 Sunshine Lake Pharma Co., Ltd. Cathepsin k inhibitor and application thereof
CN106478564B (zh) * 2015-08-29 2021-11-12 广东东阳光药业有限公司 组织蛋白酶k抑制剂及其用途
AU2020250933A1 (en) 2019-04-05 2021-10-28 Centre Hospitalier Régional Et Universitaire De Brest Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4450988B2 (ja) * 1997-11-05 2010-04-14 ノバルティス アーゲー ジペプチドニトリル
GB9723407D0 (en) * 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
AU2560300A (en) * 1999-02-20 2000-09-04 Astrazeneca Ab Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsins
EP1434769A2 (en) * 2001-10-02 2004-07-07 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cysteine proteases
CN100430052C (zh) * 2002-03-05 2008-11-05 默克弗罗斯特加拿大有限公司 组织蛋白酶半胱氨酸蛋白酶抑制剂
WO2003075863A1 (en) * 2002-03-11 2003-09-18 Kanebo Cosmetics Inc. Cosmetics

Similar Documents

Publication Publication Date Title
JP2008513472A5 (enExample)
JP2008506632A5 (enExample)
JP2009524695A5 (enExample)
EP1975266A4 (en) ULTRA-HIGH STEEL PLATE
ATE481383T1 (de) 3-aza-bicycloä3.1.0ühexanderivate
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
WO2006058700A8 (en) Acetamide compounds as fungicides
EP1938155A4 (en) BUSINESS PROCESS EXECUTE ENGINE
WO2009064374A3 (en) Oral formulations of bis(thiohydrazide amides)
ATE531717T1 (de) Neue kristalline form eines pyridazinoä4,5- büindolderivats
ITMI20051963A1 (it) Granulati espandibili a basemdi polimeri vinilaromatici dotati di migliorata espansibilita'e procedimento per la loro preparazione
NO20054767D0 (no) Sammensetninger omfattende apomorfin for inhalering i lunge
DE602005000415D1 (de) Tintenstrahl-Aufzeichnungsblatt
DE602006015298D1 (de) Superlegierungspulver
EP1945731A4 (en) ADHESIVE AGENTS
FR2901843B1 (fr) Mecanisme d'entrainement par courroie
JP2009215399A5 (enExample)
ATE533756T1 (de) N-formyl-hydroxylamin-verbindungen
BRPI0812460A2 (pt) " compostos orgânicos ".
TWI315670B (en) Substituted aryl 1,4-pyrazine derivatives
JP2009507121A5 (enExample)
JP2005298393A5 (enExample)
JP2005298653A5 (enExample)
JP2006516578A5 (enExample)
JP2008528720A5 (enExample)